S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function
- PMID: 11700302
- DOI: 10.1074/jbc.M106287200
S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function
Abstract
ATR, a human phosphatidylinositol 3-kinase-related kinase, is an important component of the cellular response to DNA damage. In the present study, we evaluated the role of ATR in modulating the response of cells to S phase-associated DNA double-stranded breaks induced by topoisomerase poisons. Prolonged exposure to low doses of the topoisomerase I poison topotecan (TPT) resulted in S phase slowing because of diminished DNA synthesis at late-firing replicons. In contrast, brief TPT exposure, as well as prolonged exposure to the topoisomerase II poison etoposide, resulted in subsequent G(2) arrest. These responses were associated with phosphorylation of the checkpoint kinase Chk1. The cell cycle responses and phosphorylation of Chk1 were markedly diminished by forced overexpression of a dominant negative, kinase-inactive allele of ATR. In contrast, deficiency of the related kinase ATM had no effect on these events. The loss of ATR-dependent checkpoint function sensitized GM847 human fibroblasts to the cytotoxic effects of the topoisomerase I poisons TPT and 7-ethyl-10-hydroxycamptothecin, as assessed by inhibition of colony formation, increased trypan blue uptake, and development of apoptotic morphological changes. Expression of kdATR also sensitized GM847 cells to the cytotoxic effects of prolonged low dose etoposide and doxorubicin, albeit to a smaller extent. Collectively, these results not only suggest that ATR is important in responding to the replication-associated DNA damage from topoisomerase poisons, but also support the view that ATM and ATR have unique roles in activating the downstream kinases that participate in cell cycle checkpoints.
Similar articles
-
Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.Mol Cancer Ther. 2004 May;3(5):621-32. Mol Cancer Ther. 2004. PMID: 15141020
-
The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons.J Biol Chem. 2005 Apr 8;280(14):14349-55. doi: 10.1074/jbc.M411890200. Epub 2005 Feb 7. J Biol Chem. 2005. PMID: 15699047
-
The dispersal of replication proteins after Etoposide treatment requires the cooperation of Nbs1 with the ataxia telangiectasia Rad3-related/Chk1 pathway.Cancer Res. 2006 Feb 1;66(3):1675-83. doi: 10.1158/0008-5472.CAN-05-2741. Cancer Res. 2006. PMID: 16452227
-
Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.Cell Cycle. 2006 Oct;5(19):2203-9. doi: 10.4161/cc.5.19.3256. Epub 2006 Oct 1. Cell Cycle. 2006. PMID: 16969104 Review.
-
Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets.Br J Cancer. 2012 Jan 3;106(1):18-24. doi: 10.1038/bjc.2011.498. Epub 2011 Nov 22. Br J Cancer. 2012. PMID: 22108516 Free PMC article. Review.
Cited by
-
Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.J Biol Chem. 2012 Feb 3;287(6):4198-210. doi: 10.1074/jbc.M111.296475. Epub 2011 Dec 12. J Biol Chem. 2012. PMID: 22158865 Free PMC article.
-
WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.J Cell Sci. 2011 Dec 1;124(Pt 23):3967-79. doi: 10.1242/jcs.081372. Epub 2011 Dec 8. J Cell Sci. 2011. PMID: 22159421 Free PMC article.
-
Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.J Biol Chem. 2009 Jun 26;284(26):17428-37. doi: 10.1074/jbc.M109.007823. Epub 2009 Apr 24. J Biol Chem. 2009. PMID: 19395378 Free PMC article.
-
HIV-1 Vpr-a still "enigmatic multitasker".Front Microbiol. 2014 Mar 31;5:127. doi: 10.3389/fmicb.2014.00127. eCollection 2014. Front Microbiol. 2014. PMID: 24744753 Free PMC article. Review.
-
Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.PLoS One. 2013;8(2):e57098. doi: 10.1371/journal.pone.0057098. Epub 2013 Feb 25. PLoS One. 2013. PMID: 23451157 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous